MEDPLUS INC /OH/
8-K, 1997-12-19
COMPUTER PERIPHERAL EQUIPMENT, NEC
Previous: SILVER JACK, SC 13D/A, 1997-12-19
Next: APARTMENT INVESTMENT & MANAGEMENT CO, 8-A12B, 1997-12-19



       UNITED STATES SECURITIES AND E CHANGE COMMISSION
                     Washington, D.C.  20549

                            FORM 8-K

                        CURRENT REPORT

            Pursuant to Section 13 or 15(d) of the     
                Securities Exchange Act of 1934

              Date of Report:  December 19, 1997



                         MEDPLUS, INC.
 (Exact name of registrant as specified in its charter)

             Ohio                        48-1094982 
(State or other jurisdiction of     (I.R.S. Employer 
incorporation or organization)     Identification No.)


          8805 Governor's Hill Drive, Suite 100
                 Cincinnati, OH  45249
       (Address of principal executive offices)

                   (513) 583-0500 
   (Registrant's telephone number, including area code)


                              N/A 
         (Former name or former address, if changed 
                     since last report)






Item 5.  Other Events.  On December 19, 1997, the 
registrant issued the attached press release announcing 
a change in its fiscal year end and that Philip S. 
Present II, its chief operating officer, has been 
elected to the registrant's board of directors  to 
fill the vacancy created by an increase in the number 
of directors from five to six. 

Item 7.  Financial Statements and Exhibits

(c)  Exhibits

99.1  Press release dated December 19, 1997.


Item 8. Change in Fiscal Year.  On December 13, 1997, 
the Board of Directors of MedPlus, Inc. (the 
"Company") authorized a change in the fiscal year of 
the Company. The date of the new fiscal year end is 
January 31, 1998. The date of the Company's old fiscal 
year end was December 31, 1997.  The transition report 
for the one month transition period of January 1997 
will be reported on the Company's Form 10-K for the 
year ending January 31, 1998.  The Form 10-K for the 
year ending January 31, 1998 will be filed on or 
before April 31, 1998.  



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 
1934, the Registrant has duly caused this Report to be signed on 
its behalf by the undersigned thereunto duly authorized.

                                 MEDPLUS, INC.



Date: December 19, 1997         By:______________________________
                                   Daniel A. Silber,
                                   Chief Financial Officer

Exhibit 99.1

FOR IMMEDIATE RELEASE             CONTACT: Philip S. Present, II
                                           Chief Operating Officer
                                           (513) 583-0500


MEDPLUS ANNOUNCES NEW BOARD MEMBER AND CHANGE IN FISCAL YEAR END

CINCINNATI, DECEMBER 18, 1997 3/4 MedPlus Inc. today announced the 
election of Philip S. Present II, chief operating officer (COO), 
to MedPlus' board of directors and the change in the company's 
fiscal year end from December 31 to January 31.  The change in 
fiscal year end is effective for the year ending January 31, 1998.

Present's election to the board will fill the vacancy created by 
an increase in the number of directors from five to six. As a 
board member, Present will assume a greater role in leading the 
direction of the company. Prior to joining MedPlus in 1995, 
Present served 22 years with the certified public accounting firm 
of KPMG Peat Marwick LLP.   


MedPlus is a publicly traded (NASDAQ:MEDP), Cincinnati-based 
company that develops, sells and supports hardware and software 
solutions to address the needs of health care organizations. 
Product offerings include electronic patient records systems, 
optical document archival and retrieval systems, intelligent bar 
coding solutions, object-oriented workflow and document management 
systems and hospital, reference laboratory and physician office 
productivity consulting.

                             ###



 





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission